The PD-L1 adorning the surface of cancer cell EVs engages with PD-1 receptors on CD8 + T cells, resulting in the impediment of CD8 + T cell proliferation and activation [71, 72] (Fig. 1A). The gene discussed is CD8A; the disease is cancer.